Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder

Objectives: Extant evidence indicates that ketamine exerts rapid antidepressant effects in treatment-resistant depressive (TRD) symptoms as a part of major depressive disorder (MDD) and bipolar disorder (BD). The identification of depressed sub-populations that are more likely to benefit from ketami...

Full description

Bibliographic Details
Main Authors: Carola Rong, Caroline Park, Joshua D. Rosenblat, Mehala Subramaniapillai, Hannah Zuckerman, Dominika Fus, Yena L. Lee, Zihang Pan, Elisa Brietzke, Rodrigo B. Mansur, Danielle S. Cha, Leanna M. W. Lui, Roger S. McIntyre
Format: Article
Language:English
Published: MDPI AG 2018-04-01
Series:International Journal of Environmental Research and Public Health
Subjects:
MDD
Online Access:http://www.mdpi.com/1660-4601/15/4/771